Logo
x

Search

Subscribe Now

agreement

Entos Entered into an Agreement with BioMarin for Gene Therapies to Treat Genetic Diseases

Entos Entered into an Agreement with BioMarin for Gene Therapies to Treat Genetic Diseases

  • November 16, 2021
Mustang Bio Signs an Exclusive WW License Agreement with Leiden University Medical Centre for Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency

Mustang Bio Signs an Exclusive WW License Agreement with Leiden University Medical Centre for Lentiviral Gene Therapy to Treat RAG...

  • November 11, 2021
Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

  • October 22, 2021
Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other C...

  • October 22, 2021
Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

  • October 22, 2021
Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Therapeutics

Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Th...

  • October 21, 2021
Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

    Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

    • March 19, 2025
    AstraZeneca and Alteogen Enter an Exclusive License Deal for ALT-B4 to Develop & Market Subcutaneous Formulations of Multiple Oncology Drugs

      AstraZeneca and Alteogen Enter an Exclusive License Deal for ALT-B4 to Develop & Market Subcutaneous Formulations of Multiple Onco...

      • March 17, 2025
      Pierre Fabre Laboratories and RedRidge Bio Enter R&D Collaboration & License Agreement for Biparatopic Antibody (BPA) Candidates

        Pierre Fabre Laboratories and RedRidge Bio Enter R&D Collaboration & License Agreement for Biparatopic Antibody (BPA) Candidates

        • March 12, 2025
        Sun Pharma to Acquire Checkpoint Therapeutics For ~$355M

          Sun Pharma to Acquire Checkpoint Therapeutics For ~$355M

          • March 10, 2025
          AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics

            AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics

            • December 16, 2024
            Inspiring Innovations: Dino Kazanis and James Swartz in a Stimulating Conversation with PharmaShots

              Inspiring Innovations: Dino Kazanis and James Swartz in a Stimulating Conversation with PharmaShots

              • December 11, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.